| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1063-4584(05)80006-8 |
| P698 | PubMed publication ID | 11548224 |
| P50 | author | Lucio C Rovati | Q61987523 |
| P2093 | author name string | M Fischer | |
| I Setnikar | |||
| W Noack | |||
| K K Förster | |||
| P433 | issue | 1 | |
| P921 | main subject | osteoarthritis | Q62736 |
| glucosamine | Q32907954 | ||
| P304 | page(s) | 51-59 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
| P1476 | title | Glucosamine sulfate in osteoarthritis of the knee | |
| P478 | volume | 2 |
| Q34588403 | A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals |
| Q35007384 | A review of articular cartilage pathology and the use of glucosamine sulfate |
| Q44302980 | A survey of self-medication practices and perceived effectiveness of glucosamine products among older adults |
| Q34525681 | Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies |
| Q34034399 | Aging and the etiopathogenesis and treatment of osteoarthritis |
| Q24186473 | Chondroitin for osteoarthritis |
| Q35196931 | Chondroprotective agents: glucosamine and chondroitin |
| Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
| Q40956426 | Current pharmacological treatment of osteoarthritis |
| Q40703708 | EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials |
| Q35549064 | EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) |
| Q44602669 | Effect of Brand's glucosamine with essence of chicken on collagen-induced arthritis in rats |
| Q36464778 | Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial |
| Q64137153 | Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials |
| Q43133299 | Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized, placebo-controlled trial. |
| Q43182266 | Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q46801560 | Effects of hexosamines and omega-3/omega-6 fatty acids on pH regulation by interleukin 1-treated isolated bovine articular chondrocytes |
| Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
| Q28081360 | Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis |
| Q34619142 | Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). |
| Q34109134 | Evidence of nutriceutical effectiveness in the treatment of osteoarthritis |
| Q46770338 | Evidence-based evaluation of study results of symptomatic glucosamine therapy |
| Q28215692 | GLUT2 is a high affinity glucosamine transporter |
| Q38362244 | Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants |
| Q37354339 | Glucosamine and chondroitin for osteoarthritis |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q35121454 | Glucosamine and chondroitin sulfate are effective inthe management of osteoarthritis |
| Q73179807 | Glucosamine in osteoarthritis |
| Q33214439 | Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials |
| Q34460174 | Glucosamine supplementation after anterior cruciate ligament reconstruction in athletes: a randomized placebo-controlled trial. |
| Q32067018 | Glucosamine therapy compared to ibuprofen for joint pain. |
| Q24244026 | Glucosamine therapy for treating osteoarthritis |
| Q35598677 | Glucosamine: a review of its use in the management of osteoarthritis |
| Q35578053 | Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different? |
| Q33870135 | Hype about glucosamine |
| Q37634998 | Is osteoarthritis a heterogeneous disease that can be stratified into subsets? |
| Q32050561 | Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial |
| Q33995634 | Management of chronic osteoarthritic pain |
| Q36374283 | Medical treatment of osteoarthritis in the horse - a review |
| Q56638267 | Medikament�se Therapie bei Arthrose |
| Q37798321 | Modern Management of Mild-to-Moderate Joint Pain due to Osteoarthritis: A Holistic Approach |
| Q80633772 | Non-NSAID over-the-counter (OTC) remedies for arthritis: good, bad or indifferent? |
| Q36209436 | Nutraceutical therapies for degenerative joint diseases: a critical review. |
| Q33651430 | Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate |
| Q38047227 | Nutraceuticals in the management of osteoarthritis : a critical review |
| Q58914626 | Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period |
| Q34976432 | Osteoarthritis: supplements and other alternative modalities |
| Q34108691 | Pharmacologic therapy of osteoarthritis |
| Q36768159 | Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study |
| Q34630468 | Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis |
| Q33727275 | Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee |
| Q40429394 | Recommended methodology for assessing the progression of osteoarthritis of the hip and knee joints |
| Q33954543 | Rheumatology: 7. Basics of therapy |
| Q34570456 | Risk assessment for glucosamine and chondroitin sulfate |
| Q34423402 | Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. |
| Q64245298 | Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
| Q47151673 | Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q53567904 | Sensitive and rapid analytical method for the quantification of glucosamine in human plasma by ultra high performance liquid chromatography with tandem mass spectrometry. |
| Q35632646 | Synthesis and characterization of a new Peptide prodrug of glucosamine with enhanced gut permeability |
| Q33239303 | The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta |
| Q37667284 | The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial |
| Q36719696 | The reverse glucosamine sulfate pathway: application in knee osteoarthritis |
| Q36793235 | The utility of nutraceuticals in the treatment of osteoarthritis |
| Q33789463 | Therapeutics of musculoskeletal disease in the horse |
| Q89072497 | Transcriptome analysis of gene expression patterns during embryonic development in golden cuttlefish (Sepia esculenta) |
| Q35578069 | Why are clinical trials of glucosamine no longer uniformly positive? |
Search more.